User profiles for Julie Dupouy

Julie Dupouy

PU MG, Département Universitaire de médecine Générale, Université Toulouse III Paul …
Verified email at dumg-toulouse.fr
Cited by 1273

Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta …

…, P Padmanathan, G Cousins, J Dupouy… - JAMA …, 2021 - jamanetwork.com
Importance Mortality among people with opioid dependence is higher than that of the general
population. Opioid agonist treatment (OAT) is an effective treatment for opioid dependence…

Patterns of gabapentin and pregabalin use and misuse: results of a population‐based cohort study in France

D Driot, E Jouanjus, S Oustric, J Dupouy… - British journal of …, 2019 - Wiley Online Library
Aims The aim of this study was to assess the use and factors associated with the misuse of
gabapentin and pregabalin in the general French population, through a cohort study in the …

Overview of drug data within French health insurance databases and implications for pharmacoepidemiological studies

…, G Moulis, F Despas, J Dupouy… - Fundamental & …, 2016 - Wiley Online Library
In this study, we aimed to provide an updated overview of drug data contained in the French
health insurance database ( SNIIRAM ) and its associated national representative sample ( …

Benzodiazepines and risk of death: Results from two large cohort studies in France and UK

A Palmaro, J Dupouy, M Lapeyre-Mestre - European …, 2015 - Elsevier
Benzodiazepines are widely prescribed for the treatment of anxiety or insomnia, but their
impact on mortality is still debated. This study investigated the impact of benzodiazepine use on …

[HTML][HTML] Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE)

…, J Chastang, L Piroth, C Binquet, J Dupouy… - Clinical Microbiology …, 2022 - Elsevier
Objectives To assess the efficacy of inhaled ciclesonide in reducing the risk of adverse
outcomes in COVID-19 outpatients at risk of developing severe illness. Methods COVERAGE is …

Mortality associated with time in and out of buprenorphine treatment in French office-based general practice: a 7-year cohort study

J Dupouy, A Palmaro, M Fatséas… - The Annals of Family …, 2017 - Annals Family Med
In France, most cases of opioid use disorder are treated with buprenorphine by general
practitioners in private practice. Using reimbursement data of a representative sample of the …

[HTML][HTML] Home treatment of older people with symptomatic SARS-CoV-2 infection (COVID-19): a structured summary of a study protocol for a multi-arm multi-stage …

…, JF Michel, B Lefèvre, D Lebeaux, J Lebel, J Dupouy… - Trials, 2020 - Springer
Objectives To assess the efficacy of several repurposed drugs to prevent hospitalisation or
death in patients aged 65 or more with recent symptomatic SARS-CoV-2 infection (COVID-19…

Does urine drug abuse screening help for managing patients? A systematic review

J Dupouy, V Memier, H Catala, M Lavit, S Oustric… - Drug and Alcohol …, 2014 - Elsevier
Julie Dupouy was involved in all stages of the project from design, writing of the protocol, …
Julie Dupouy wrote the first draft of the manuscript, and all authors contributed to and have …

Disproportionality analysis for the assessment of abuse and dependence potential of pregabalin in the French pharmacovigilance database

JB Bossard, C Ponté, J Dupouy… - Clinical drug …, 2016 - Springer
Background and Objective Pregabalin abuse and dependence has been increasingly
described; however, it is not described in France. Our study aimed to investigate the abuse and …

Baclofen for alcohol dependence in France: incidence of treated patients and prescription patterns—a cohort study

J Dupouy, JP Fournier, É Jouanjus, A Palmaro… - European …, 2014 - Elsevier
Recently, baclofen has been widely promoted for treatment of alcohol dependence in France.
Our aim was firstly to describe the incidence of patients newly treated with baclofen for …